BioCentury | Jul 27, 2018
Company News

Sangamo acquiring TxCell, accelerates CAR Treg development

...annual report, TxCell raised €82 million in equity from 2001 to 2017. The report lists Auriga Partners...
BioCentury | Jul 23, 2018
Company News

Sangamo acquiring TxCell, accelerates CAR Treg development

...annual report, TxCell raised €82 million in equity from 2001 to 2017. The report lists Auriga Partners...
BioCentury | Jul 13, 2018
Financial News

Nextbiotix raises EUR7M series A round to bring IBD therapy into clinic

...France) raised €7 million ($8.1 million) in a series A round led by new investor Auriga Partners...
BioCentury | Jul 5, 2018
Financial News

Nextbiotix raises €7M series A for microbiome-based therapy

...S.A.S. (Dijon, France) raised €7 million ($8.1 million) in a series A round led by Auriga Partners...
...therapy is in preclinical testing for Crohn's disease, ulcerative colitis and irritable bowel syndrome (IBS). Allison Johnson Auriga Partners Biocodex Cap...
BioCentury | Jan 19, 2018
Financial News

Pherecydes raises €8.7M series B

...Fa Dièse and other undisclosed new investors also participated, along with existing investors ACE Management, Auriga Partners...
BioCentury | Mar 31, 2017
Financial News

Nosopharm completes venture financing

...S.A.S. (Nimes, France) raised €2.4 million ($2.6 million) in a venture round from new investors Auriga Partners...
BioCentury | Jun 24, 2015
Financial News

Financial tracks

...director of companion diagnostics at AstraZeneca plc (LSE:AZN; NYSE:AZN), and Peltier was a partner at Auriga Partners. BC...
BioCentury | Jan 19, 2015
Financial News

CoLucid completes venture financing

...Neurology Date completed: 2015-01-13 Type: Venture financing Raised: $37.1 million Investors: TVM Capital; Novo Ventures; Auriga Partners...
BioCentury | Jan 14, 2015
Financial News

Migraine play CoLucid raises $37.1M

...series C round led by TVM Capital Life Science. New investors included Novo Ventures and Auriga Partners...
BioCentury | Sep 1, 2014
Financial News

Median Technologies proposes private placement of units

...outstanding prior: 6 million Placement agent: Cowen Investors: New Enterprise Associates; Omega Funds; Abingworth Management; Auriga Partners...
Items per page:
1 - 10 of 52
BioCentury | Jul 27, 2018
Company News

Sangamo acquiring TxCell, accelerates CAR Treg development

...annual report, TxCell raised €82 million in equity from 2001 to 2017. The report lists Auriga Partners...
BioCentury | Jul 23, 2018
Company News

Sangamo acquiring TxCell, accelerates CAR Treg development

...annual report, TxCell raised €82 million in equity from 2001 to 2017. The report lists Auriga Partners...
BioCentury | Jul 13, 2018
Financial News

Nextbiotix raises EUR7M series A round to bring IBD therapy into clinic

...France) raised €7 million ($8.1 million) in a series A round led by new investor Auriga Partners...
BioCentury | Jul 5, 2018
Financial News

Nextbiotix raises €7M series A for microbiome-based therapy

...S.A.S. (Dijon, France) raised €7 million ($8.1 million) in a series A round led by Auriga Partners...
...therapy is in preclinical testing for Crohn's disease, ulcerative colitis and irritable bowel syndrome (IBS). Allison Johnson Auriga Partners Biocodex Cap...
BioCentury | Jan 19, 2018
Financial News

Pherecydes raises €8.7M series B

...Fa Dièse and other undisclosed new investors also participated, along with existing investors ACE Management, Auriga Partners...
BioCentury | Mar 31, 2017
Financial News

Nosopharm completes venture financing

...S.A.S. (Nimes, France) raised €2.4 million ($2.6 million) in a venture round from new investors Auriga Partners...
BioCentury | Jun 24, 2015
Financial News

Financial tracks

...director of companion diagnostics at AstraZeneca plc (LSE:AZN; NYSE:AZN), and Peltier was a partner at Auriga Partners. BC...
BioCentury | Jan 19, 2015
Financial News

CoLucid completes venture financing

...Neurology Date completed: 2015-01-13 Type: Venture financing Raised: $37.1 million Investors: TVM Capital; Novo Ventures; Auriga Partners...
BioCentury | Jan 14, 2015
Financial News

Migraine play CoLucid raises $37.1M

...series C round led by TVM Capital Life Science. New investors included Novo Ventures and Auriga Partners...
BioCentury | Sep 1, 2014
Financial News

Median Technologies proposes private placement of units

...outstanding prior: 6 million Placement agent: Cowen Investors: New Enterprise Associates; Omega Funds; Abingworth Management; Auriga Partners...
Items per page:
1 - 10 of 52